Chantal Mathieu

74.9k total citations · 21 hit papers
870 papers, 47.3k citations indexed

About

Chantal Mathieu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Chantal Mathieu has authored 870 papers receiving a total of 47.3k indexed citations (citations by other indexed papers that have themselves been cited), including 369 papers in Endocrinology, Diabetes and Metabolism, 305 papers in Surgery and 248 papers in Genetics. Recurrent topics in Chantal Mathieu's work include Diabetes Management and Research (262 papers), Pancreatic function and diabetes (238 papers) and Diabetes and associated disorders (216 papers). Chantal Mathieu is often cited by papers focused on Diabetes Management and Research (262 papers), Pancreatic function and diabetes (238 papers) and Diabetes and associated disorders (216 papers). Chantal Mathieu collaborates with scholars based in Belgium, United States and France. Chantal Mathieu's co-authors include Roger Bouillon, Conny Gysemans, Evelyne van Etten, John B. Buse, Melanie J. Davies, Annemieke Verstuyf, Peter Rossing, Geltrude Mingrone, Απόστολος Τσάπας and Annapaula Giulietti and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Chantal Mathieu

839 papers receiving 45.8k citations

Hit Papers

Management of Hyperglyce... 1999 2026 2008 2017 2018 2008 2018 2001 2010 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2018 2.6k citations Chantal Mathieu et al. profile →
  2. Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
    2008 1.3k citations Roger Bouillon, Geert Carmeliet et al. profile →
  3. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2018 1.1k citations Chantal Mathieu et al. Diabetologia profile →
  4. An Overview of Real-Time Quantitative PCR: Applications to Quantify Cytokine Gene Expression
    2001 1.1k citations Roger Bouillon, Chantal Mathieu et al. profile →
  5. Vitamin D: modulator of the immune system
    2010 990 citations Conny Gysemans, Chantal Mathieu et al. profile →
  6. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2022 947 citations Stefano Del Prato, Chantal Mathieu et al. profile →
  7. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2019 834 citations Chantal Mathieu et al. profile →
  8. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts
    2005 687 citations Chantal Mathieu et al. profile →
  9. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
    2012 651 citations Chantal Mathieu et al. profile →
  10. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2022 532 citations Stefano Del Prato, Chantal Mathieu et al. Diabetologia profile →
  11. QUANTIFICATION OF MURINE CYTOKINE mRNAs USING REAL TIME QUANTITATIVE REVERSE TRANSCRIPTASE PCR
    1999 521 citations Lut Overbergh, Chantal Mathieu et al. profile →
  12. Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
    2016 505 citations Chantal Mathieu et al. Diabetes profile →
  13. Initiation and execution of lipotoxic ER stress in pancreatic β-cells
    2008 501 citations Daniel A. Cunha, Chantal Mathieu et al. profile →
  14. [Management of hyperglycaemia in type 2 diabetes: a patient-centered approach].
    2012 467 citations Chantal Mathieu et al. profile →
  15. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    2019 352 citations Chantal Mathieu et al. Diabetologia profile →
  16. Vitamin D’s Effect on Immune Function
    2020 285 citations Pieter-Jan Martens, Conny Gysemans et al. Nutrients profile →
  17. Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
    2023 193 citations Chantal Mathieu et al. profile →
  18. COVID-19, Hyperglycemia, and New-Onset Diabetes
    2021 184 citations Stefano Del Prato, Chantal Mathieu et al. profile →
  19. Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective
    2022 117 citations Mikael Knip, Chantal Mathieu et al. Diabetes profile →
  20. Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
    2023 86 citations Chantal Mathieu et al. profile →
  21. Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial
    2024 55 citations Katrien Benhalima, Dominique Ballaux et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chantal Mathieu Belgium 105 17.2k 11.0k 10.6k 9.8k 8.8k 870 47.3k
Roger Bouillon Belgium 102 13.0k 0.8× 4.9k 0.4× 16.8k 1.6× 8.2k 0.8× 6.4k 0.7× 585 46.0k
Sundeep Khosla United States 113 6.4k 0.4× 7.8k 0.7× 4.8k 0.5× 21.3k 2.2× 6.6k 0.8× 511 51.8k
Claus Christiansen Denmark 108 7.7k 0.4× 6.4k 0.6× 5.5k 0.5× 11.3k 1.2× 7.3k 0.8× 681 45.7k
Ronald M. Krauss United States 104 18.5k 1.1× 13.1k 1.2× 1.7k 0.2× 7.9k 0.8× 4.3k 0.5× 380 48.7k
Nader Rifai United States 122 16.5k 1.0× 21.1k 1.9× 2.6k 0.2× 9.2k 0.9× 3.4k 0.4× 455 77.6k
Richard N. Bergman United States 99 16.1k 0.9× 9.3k 0.8× 2.2k 0.2× 10.9k 1.1× 6.0k 0.7× 623 42.3k
Friedrich C. Luft Germany 112 9.1k 0.5× 6.8k 0.6× 2.2k 0.2× 12.8k 1.3× 2.3k 0.3× 1.1k 50.6k
Amirhossein Sahebkar Iran 127 7.3k 0.4× 9.2k 0.8× 2.9k 0.3× 22.9k 2.3× 1.9k 0.2× 1.9k 69.4k
Herbert Tilg Austria 87 5.6k 0.3× 5.8k 0.5× 3.0k 0.3× 12.1k 1.2× 3.5k 0.4× 452 40.3k
Anthony Cerami United States 135 9.0k 0.5× 4.7k 0.4× 3.9k 0.4× 18.8k 1.9× 4.0k 0.5× 514 76.7k

Countries citing papers authored by Chantal Mathieu

Since Specialization
Citations

This map shows the geographic impact of Chantal Mathieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantal Mathieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantal Mathieu more than expected).

Fields of papers citing papers by Chantal Mathieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantal Mathieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantal Mathieu. The network helps show where Chantal Mathieu may publish in the future.

Co-authorship network of co-authors of Chantal Mathieu

This figure shows the co-authorship network connecting the top 25 collaborators of Chantal Mathieu. A scholar is included among the top collaborators of Chantal Mathieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantal Mathieu. Chantal Mathieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moulder, Robert, Tommi Välikangas, Tomi Suomi, et al.. (2025). Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease. Diabetologia. 68(6). 1108–1114.
2.
Ballaux, Dominique, Gerd Vanhaverbeke, Youri Taes, et al.. (2025). Cost-effectiveness of advanced hybrid closed loop therapy compared to standard insulin therapy for type 1 diabetes in pregnancy: an economic evaluation of the CRISTAL trial. EClinicalMedicine. 81. 103106–103106. 2 indexed citations
3.
Lemaître, Pierre, Chantal Mathieu, & Conny Gysemans. (2024). Protocol for murine multi-tissue deep immunophenotyping using a 40-color full-spectrum flow cytometry panel. STAR Protocols. 5(4). 103492–103492. 1 indexed citations
4.
5.
Charleer, Sara, Steffen Fieuws, Christophe De Block, et al.. (2022). The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial. Journal of Diabetes Science and Technology. 18(3). 660–666. 5 indexed citations
6.
Mathieu, Chantal, et al.. (2022). Diabetic Ketoacidosis After Sodium–Glucose Cotransporter Inhibitor Initiation Under Advanced Hybrid Closed-Loop Therapy in Type 1 Diabetes. Diabetes Technology & Therapeutics. 24(7). 516–519. 4 indexed citations
7.
Baekelandt, Jan, Chantal Mathieu, Annouschka Laenen, et al.. (2021). Adnexectomy by vaginal Natural Orifice Transluminal Endoscopic Surgery versus laparoscopy: results of a first randomised controlled trial (NOTABLE trial). BJOG An International Journal of Obstetrics & Gynaecology. 128(11). 1782–1791. 41 indexed citations
8.
Tilvawala, Ronak, Dana P. Cook, Claire Berthault, et al.. (2020). Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice. Diabetes. 70(2). 516–528. 33 indexed citations
9.
Martens, Pieter-Jan, Conny Gysemans, Annemieke Verstuyf, & Chantal Mathieu. (2020). Vitamin D’s Effect on Immune Function. Nutrients. 12(5). 1248–1248. 285 indexed citations breakdown →
10.
Mathieu, Chantal, Stefano Del Prato, Fady T. Botros, et al.. (2018). Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme. Diabetes Obesity and Metabolism. 20(8). 2023–2028. 15 indexed citations
11.
Woo, et al.. (2015). Canagliflozin reduces both HbA(1c) and body weight in patients with type 2 diabetes on background dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 agonists. Diabetologia. 58. 3 indexed citations
12.
Åhrén, Bo, Chantal Mathieu, Giovanni Bader, Anja Schweizer, & James E. Foley. (2014). Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies. Diabetologia. 57(7). 1304–1307. 37 indexed citations
13.
Brath, Helmut, Alfred Penfornis, Ignacio Conget, et al.. (2014). Real life effectiveness and safety of vildagliptin compared with other OADs in European type 2 diabetes mellitus patients: results from the EDGE study. Diabetologia. 57. 1 indexed citations
14.
Meininger, Gary, et al.. (2013). Canagliflozin added on to dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 agonists with or without other antihyperglycaemic agents in type 2 diabetes mellitus. Diabetologia. 56.
15.
Cunha, Daniel A., Mariana Igoillo‐Esteve, Esteban N. Gurzov, et al.. (2012). Death Protein 5 and p53-Upregulated Modulator of Apoptosis Mediate the Endoplasmic Reticulum Stress–Mitochondrial Dialog Triggering Lipotoxic Rodent and Human β-Cell Apoptosis. Diabetes. 61(11). 2763–2775. 111 indexed citations
16.
Declercq, Jeroen, Anujith Kumar, Conny Gysemans, et al.. (2011). Pdx1- and Ngn3-Cre-Mediated PLAG1 Expression in the Pancreas Leads to Endocrine Hormone Imbalances That Affect Glucose Metabolism. Cell Transplantation. 20(8). 1285–1297. 3 indexed citations
17.
Storms, Gert, I M Colin, Thiemo Veneman, & Chantal Mathieu. (2010). Switching from premixed insulin to basal-bolus insulin glargine plus rapid-acting insulin: results of the ATLANTIC study. Diabetologia. 53. 1 indexed citations
18.
Verstuyf, Annemieke, Geert Carmeliet, Roger Bouillon, & Chantal Mathieu. (2010). Vitamin D: a pleiotropic hormone. Kidney International. 78(2). 140–145. 259 indexed citations
19.
Borgermans, Liesbeth, Geert Goderis, C. van den Broeke, et al.. (2008). A cluster randomized trial to improve adherence to evidence-based guidelines on diabetes and reduce clinical inertia in primary care physicians in Belgium: study protocol [NTR 1369]. Implementation Science. 3(1). 42–42. 13 indexed citations
20.
Freemantle, Nick, Chantal Mathieu, & Hans Hauner. (2006). Replicating the PROactive trial of pioghtazone in subjects with diabetes and raised cardiovascular risk with the EAGLE model. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger Bouillon Breakdown of academic impact, for papers by Sundeep Khosla Breakdown of academic impact, for papers by Claus Christiansen Breakdown of academic impact, for papers by Ronald M. Krauss Breakdown of academic impact, for papers by Nader Rifai Breakdown of academic impact, for papers by Richard N. Bergman Breakdown of academic impact, for papers by Friedrich C. Luft Breakdown of academic impact, for papers by Amirhossein Sahebkar Breakdown of academic impact, for papers by Herbert Tilg Breakdown of academic impact, for papers by Anthony Cerami
Rankless by CCL
2026